Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 46

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Dec 14, 2014; 20(46): 17648-17655
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17648

Full Size Figure Download Figure

Figure 3 Forest plot to show the pooled estimates of progression free survival.

Citation: Zhang X, Huang HJ, Feng D, Yang DJ, Wang CM, Cai QP. Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer? World J Gastroenterol 2014; 20(46): 17648-17655
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17648.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17648

Zhang X, Huang HJ, Feng D, Yang DJ, Wang CM, Cai QP. Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer? World J Gastroenterol 2014; 20(46): 17648-17655 [PMID: 25516680 DOI: 10.3748/wjg.v20.i46.17648]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.